Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 2/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.39 |
| ▸ | LPL | P06858 | 7/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.35 |
| ▸ | KDR | P35968 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24478930 | 1.00 | SNCA (0.47) | SNCACYP19A1LPLLIPGEGFR | |
| SCHEMBL29081683 | 0.88 | KDM4E (0.52) | SNCACYP19A1LPLLIPGKDM4E | |
| SCHEMBL593486 | 0.83 | SNCA (0.57) | SNCALPLLIPGKDM4EALDH1A1 | |
| SCHEMBL29082234 | 0.82 | SNCA (0.56) | SNCALPLLIPGKDM4EALDH1A1 | |
| SCHEMBL24366503 | 0.81 | RAB9A (0.54) | SNCACYP19A1LPLLIPGKDM4E | |
| SCHEMBL489516 | 0.81 | HSD17B10 (0.49) | SNCALPLLIPGALDH1A1NPC1 | |
| SCHEMBL24479134 | 0.80 | SNCA (0.42) | SNCALPLLIPGEGFRKDM4E | |
| SCHEMBL31689373 | 0.80 | SNCA (0.42) | SNCALPLLIPGEGFRKDM4E | |
| SCHEMBL24366834 | 0.80 | SNCA (0.43) | SNCALPLLIPGEGFRSMN1; SMN2 | |
| SCHEMBL24365639 | 0.79 | SNCA (0.45) | SNCALPLLIPGKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12433159-B2 | Organic compound, and organic light emitting diode and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2025-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12433159-B2 | Organic compound, and organic light emitting diode and organic light emitting device including the same | SLCO4C1, SLCO2A1, SLCO2B1 | SNCA 1335/4885CYP19A1 1545/4885LPL 345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.